$1.62 +0.02 (1.25%) NanoViricides Inc - NYSE Amex Equities

Sep. 23, 2016 | 04:00 PM
Key Statistics
Last Trade: 1.62
Trade Time: Sep 23 04:00 PM Eastern Daylight Time
Change: +0.02 (1.25%)
Prev Close: 1.60
Open: 1.58
Bid: 1.50
Ask: 1.89

Competitors

Ticker Name Volume % Change
MSTX Mast Therapeutics Inc. 23.15M -4.28%
MDVN Medivation Inc. 16.11M +0.42%
BLRX BioLineRx Ltd 9.19M +26.73%
GILD Gilead Sciences Inc. 7.53M -0.18%
MNKD MannKind Corporation 7.51M -9.75%

NNVC Stock Analysis

  1. No results found.

Partner Headlines

  1. NanoViricides Reports that the Dramatic Effects of Its Topical Anti-Herpes Treatment ...

    Benzinga | Aug. 17, 2015 | 07:08AM EST
  2. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  3. Biotechs That Might Benefit From Ebola

    Benzinga | Aug. 11, 2014 | 15:29PM EST
  4. Ebola Stocks Continue Higher

    Benzinga | Aug. 4, 2014 | 14:14PM EST
  5. UPDATE: NanoViricides Calls SeekingAlpha Article 'Baseless,' 'Inaccurate'

    Benzinga | Feb. 11, 2014 | 13:30PM EST
  6. NanoViricides Reports FluCide Well-Tolerated in non-GLP Small Animal Tox Study

    Benzinga | Oct. 21, 2013 | 07:15AM EST